UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000056844
Receipt number R000064967
Scientific Title Goal of Dynamic Strategy by Aggressive Lipid Intervention in Acute Myocardial Infarction
Date of disclosure of the study information 2025/02/02
Last modified on 2025/01/28 16:44:41

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Goal of Dynamic Strategy by Aggressive Lipid Intervention in Acute Myocardial Infarction

Acronym

GOODBYLIPID-AMI

Scientific Title

Goal of Dynamic Strategy by Aggressive Lipid Intervention in Acute Myocardial Infarction

Scientific Title:Acronym

GOODBYLIPID-AMI

Region

Japan


Condition

Condition

Acute Myocardial Infarction

Classification by specialty

Medicine in general Cardiology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To evaluate the efficacy of lipid-lowering therapy for residual coronary plaque in patients undergoing percutaneous coronary intervention by cardiac catheter for acute myocardial infarction

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

Since this is an exploratory study to determine the efficacy of lipid-lowering therapy for residual coronary plaque in non-culprit lesions in patients undergoing PCI for AMI, the principal investigator or investigators will determine the endpoints and analysis methods after data collection.

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit

85 years-old >=

Gender

Male and Female

Key inclusion criteria

Patients who meet all of the following eligibility criteria
(1) 18 years of age or older and less than 85 years of age
(2) Have one of the following residual lesions at the time of PCI for AMI
i) Coronary angiographic stenosis between 25% and 75%.
ii) Coronary angiographic stenosis of 75% to less than 90% and FFR >0.80 or Resting Index >0.89
(3) Fasting LDL-C level >55 mg/dL during hospitalization
(4) Written consent for participation in the study is obtained from the patient.

Key exclusion criteria

(1) eGFR<30 ml/min/1.73m2
(2) Current or historical use of PCSK9 inhibitors or sustained LDL-C-lowering siRNA agents
(3) Scheduled PCI or CABG for residual coronary artery lesions under study
(4) Complicated congenital heart disease
(5) Patients with a permanent pacemaker or internal defibrillation leads
(6) Patients after artificial heart valve replacement
(7) Patients with arrhythmia or tachycardia that interferes with CT data acquisition
(8) Patients with body mass index (BMI) >35
(9) Patients with contraindication to nitrates
(10) Patients with no prognosis for more than 1-year
(11) Patients who participated in clinical trials with other drugs
(11) Patients participating in clinical trials with other drugs
(12) Patients under conditions that may interfere with patient safety or protocol compliance
(13) Patients who are deemed unsuitable by the principal investigator or sub investigator

Target sample size

300


Research contact person

Name of lead principal investigator

1st name Tomoya
Middle name
Last name Ueda

Organization

Nara Medical University

Division name

Department of Cardiovascular Medicine

Zip code

634-8522

Address

840 Shijo-cho, Kashihara, Nara, Japan

TEL

0744-22-3051

Email

tom15@naramed-u.ac.jp


Public contact

Name of contact person

1st name Kazutaka
Middle name
Last name Nogi

Organization

Nara Medical University

Division name

Department of Cardiovascular Medicine

Zip code

634-8522

Address

840 Shijo-cho, Kashihara, Nara, Japan

TEL

0744-22-3051

Homepage URL


Email

nogi18kazu@dream.jp


Sponsor or person

Institute

Nara Medical University

Institute

Department

Personal name



Funding Source

Organization

Self-funding

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Nara Medical University Research Ethics Committee

Address

840 Shijo-cho, Kashihara, Nara, Japan

Tel

0744-22-3051

Email

ino_rinri@naramed-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

奈良県立医科大学附属病院、奈良県総合医療センター、奈良県西和医療センター、市立奈良病院


Other administrative information

Date of disclosure of the study information

2025 Year 02 Month 02 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2024 Year 10 Month 08 Day

Date of IRB

2025 Year 01 Month 22 Day

Anticipated trial start date

2025 Year 02 Month 02 Day

Last follow-up date

2032 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Evaluate the efficacy of lipid-lowering therapy for residual coronary plaque in patients undergoing percutaneous coronary intervention by cardiac catheter for acute myocardial infarction


Management information

Registered date

2025 Year 01 Month 28 Day

Last modified on

2025 Year 01 Month 28 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000064967